Elanco Animal Health Inc (NYSE:ELAN)
$ 14.07 -0.43 (-2.97%) Market Cap: 6.96 Bil Enterprise Value: 10.82 Bil PE Ratio: 35.18 PB Ratio: 1.07 GF Score: 72/100

Elanco Animal Health Inc at Goldman Sachs Healthcare Conference Transcript

Jun 12, 2023 / 09:40PM GMT
Release Date Price: $9.36 (+3.31%)
Nathan Allen Rich
Goldman Sachs Group, Inc., Research Division - Research Analyst

All right. Great. Well, good afternoon, everyone, and thanks for joining this session with Elanco. We're very pleased to have Jeff Simmons, President and CEO, with us for a fireside chat today. I guess, Jeff, maybe to start, it's been about 2.5 years since the Analyst Day.

Questions & Answers

Nathan Allen Rich
Goldman Sachs Group, Inc., Research Division - Research Analyst

A lot changed from a macro standpoint, competitive landscape has changed. What you have in the pipeline. You've done some deals in that time. Could you maybe just talk about what's played out over those 2.5 years? And then when we think about the next 2 to 3 years, kind of what's your vision for what you want to see the company deliver over that period?

Jeffrey N. Simmons
Elanco Animal Health Incorporated - President, CEO & Director

Sure. Thank you. Thanks for the opportunity, Nate, and great to be here at the Goldman Conference. So yes, I think in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot